MindWalk (NASDAQ:HYFT) Stock Price Down 5.8% – Time to Sell?

MindWalk Holdings Corp. (NASDAQ:HYFT) shares fell 5.8% during mid-day trading on Friday. The company traded as low as $1.10 and last traded at $1.13. 195,327 shares traded hands during trading, a decline of 39% from the average daily volume of 320,022 shares. The stock had previously closed at $1.20.

Analyst Upgrades and Downgrades

HYFT has been the subject of a number of recent analyst reports. Weiss Ratings raised MindWalk from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday. Wall Street Zen upgraded shares of MindWalk from a “sell” rating to a “hold” rating in a report on Saturday, August 15th. HC Wainwright reaffirmed a “buy” rating on shares of MindWalk in a research note on Monday, July 20th. Finally, Zacks Research raised shares of MindWalk from a “strong sell” rating to a “hold” rating in a research report on Monday, September 21st. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, MindWalk presently has a consensus rating of “Moderate Buy” and a consensus price target of $5.00.

MindWalk Stock Performance

The company has a market cap of $52.78 million, a price-to-earnings ratio of -4.35 and a beta of 0.77. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.84 and a quick ratio of 1.75. The stock has a 50-day moving average price of $1.34 and a 200 day moving average price of $1.40.

MindWalk (NASDAQ:HYFT) last issued its quarterly earnings data on Monday, September 14th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.04). MindWalk had a negative net margin of 105.11% and a negative return on equity of 133.26%. The business had revenue of $2.73 million during the quarter, compared to analyst estimates of $3.25 million. As a group, analysts anticipate that MindWalk Holdings Corp. will post -0.28 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in MindWalk stock. BlackRock Inc. acquired a new position in shares of MindWalk Holdings Corp. (NASDAQ:HYFT) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 154,411 shares of the company’s stock, valued at approximately $244,000. BlackRock Inc. owned 0.33% of MindWalk as of its most recent SEC filing. Institutional investors and hedge funds own 6.70% of the company’s stock.

MindWalk Company Profile

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation.